CLD | IBD | RA |
---|---|---|
• Change in model for end-stage liver disease (MELD) scores over the 24-week period. • Complications of CLD (frequency of ascitic paracentesis, number of hospital admissions, the incidence of serious infections such a spontaneous bacterial peritonitis). • For those who undergo LT, post-operative complications, e.g. length of admission. • Transplant free survival time. • Quality of life measures. • Physical activity indices. | • Change in clinical status. • Change in mucosal healing, as defined by Travis et al, [45], symptoms scoring including Harvey Bradshaw Index scoring and severity staging including Mayo scoring. • Complications of IBD (number of hospital admissions, number of acute flares). • Quality of Life measures. • Physical activity indices. | • Change in disease activity (ACR response criteria, DAS28 response, achievement of ACR/EULAR remission criteria). • Complications of RA (number of hospital admissions, number of acute flares) • Quality of life measures. • Physical activity indices. |